M&A · Healthcare · Buyer's industry: Pharmaceutical Preparations
Panbela Therapeutics, Inc. to acquire Cancer Prevention Pharmaceuticals
Announced Feb 22, 2022 · Closed Jun 16, 2022 · Private target
Deal value—
Premium—To unaffected price
EV / Adj. EBITDA—
ConsiderationNot disclosed
Transaction
- Acquirer
- Panbela Therapeutics, Inc. (PBLA)
- Target
- Cancer Prevention Pharmaceuticals
- Buyer type
- Strategic
- Offer price per share
- —
- Enterprise value
- —
- Status
- Closed Jun 16, 2022
Deal protections
Not disclosed for private-company acquisitions.
Advisors
- To the acquirer
- Canaccord Genuity
- To the target
- Not disclosed
Classification
- Sector
- Healthcare
- Buyer's industry
- Pharmaceutical Preparations